info@optogenix.com VIA BARSANTI, 20, 73010, Arnesano, LECCE

MICRO-TECHNOLOGISTS AND NEUROSCIENTISTS

A Scientists-run
company

Engineering driven by neuroscience experimental needs

More Info Contact Us
// Who we are

micro and nanotechnologies

for neuroscience research

// our story in stages

Milestones

1

2014

Optogenix is founded as a spin-off of IIT

2

2016

Tapered-fiber Probes start to be used more and more worldwide

3

2017

OptogeniX starts selling its own equipement for site-selective operation of tapered fibers

4

2018

First independent publication in which Lambda Fibers are successfully employed

5

2019

Tapered fibers are established for use in Fiber Photometry

//Team

Leonardo Sileo

CEO/Founder

biography

https://www.optogenix.com/wp-content/uploads/2021/07/leonardo.png

Leonardo Sileo

CEO/Founder

Marco Pisanello

Product Engineering

biography

https://www.optogenix.com/wp-content/uploads/2021/07/marco.png

Marco Pisanello

Product Engineering
// Founders

biography

https://www.optogenix.com/wp-content/uploads/2021/07/sabatini.png
Obtained a PhD from the Department of Neurobiology and his MD degree from the Harvard/Massachusetts Institute of Technology Program in Health Sciences and Technology in 1999. Dr. Sabatini did a postdoctoral fellowship in the laboratory of Dr. Karel Svoboda at Cold Spring Harbor Laboratory in New York. After his postdoctoral research, Dr. Sabatini joined the faculty in the Department of Neurobiology at Harvard Medical School in 2001. In 2008 Dr. Sabatini was named an investigator of the Howard Hughes Medical Institute and in 2010 was named the Takeda Professor of Neurobiology at Harvard Medical School. His laboratory focuses on understanding the function and regulation of synapses in the mammalian brain with a particular interest in how the function of synapses is perturbed in human disease such as autism, Parkinson’s, and Alzheimer’s. In order to conduct their studies, Dr. Sabatini’s laboratory creates new optical and chemical methods to be able to observe and manipulate the biochemical signaling associated with synapse function.

Bob Datta

Founder

biography

https://www.optogenix.com/wp-content/uploads/2021/07/datta.png

Bob Datta

Founder
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using ‘Content here.

John Assad

Founder

biography

https://www.optogenix.com/wp-content/uploads/2021/08/assad.png

John Assad

Founder

Sign up to get Latest Updates

optogenix in 90 seconds

Leonardo Sileo (CEO) presents our company

    NEED HELP?

    Send us a message

    Select your currency
    EUR Euro